The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


Comparison between two biodegradable polymer-based sirolimus-eluting stents with differing drug elution and polymer absorption kinetics: two-year clinical outcomes of the PANDA III trial

EuroIntervention 2018;14:e1029-e1037 published online February 2018 published online e-edition October 2018. DOI: 10.4244/EIJ-D-17-00946

1. Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing, China; 2. Chinese PLA 252 Hospital, Baoding, China; 3. Kaifeng Central Hospital, Kaifeng, China; 4. Yunnan St. John’s Hospital, Kunming, China;

Aims: In the PANDA III trial, the novel poly-lactide-co-glycolide polymer-based BuMA sirolimus-eluting stent (SES) was non-inferior to the polylactide polymer-based Excel SES for the prim

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Hybrid percutaneous treatment of iatrogenic coronary artery dissection complicating a spontaneous coronary artery dissection